Trade Summary

3 days ago, Palleiko Benjamin L, serving as CEO at Kalvista Pharmaceuticals, Inc. (KALV), sold 1,129 shares at $26.76 per share, for a total transaction value of $30,212.00. Following this transaction, Palleiko Benjamin L now holds 467,665 shares of KALV.

The trade was executed on Monday, May 18, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, May 19, 2026 at 4:03 PM ET, 1 day after the trade was made.

Kalvista Pharmaceuticals, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.